| Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ... Annals of neurology 89 (4), 780-789, 2021 | 483 | 2021 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of Clinical and Translational Neurology 8 (8), 1738-1744, 2021 | 110 | 2021 |
| COVID-19 and Guillain–Barré syndrome: a case report and review of literature A Zito, E Alfonsi, D Franciotta, M Todisco, M Gastaldi, M Cotta Ramusino, ... Frontiers in neurology 11, 909, 2020 | 98 | 2020 |
| COVID-19 severity in multiple sclerosis: putting data into context MP Sormani, I Schiavetti, L Carmisciano, C Cordioli, M Filippi, M Radaelli, ... Neurology: Neuroimmunology & Neuroinflammation 9 (1), e1105, 2021 | 70 | 2021 |
| SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study MP Sormani, I Schiavetti, D Landi, L Carmisciano, N De Rossi, C Cordioli, ... Multiple Sclerosis Journal 28 (7), 1034-1040, 2022 | 44 | 2022 |
| BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset M Puthenparampil, L Federle, S Miante, A Zito, E Toffanin, S Ruggero, ... Journal of neuroinflammation 14, 1-9, 2017 | 38 | 2017 |
| Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset M Puthenparampil, A Zito, G Pantano, L Federle, E Stropparo, S Miante, ... Multiple Sclerosis Journal 25 (7), 918-926, 2019 | 29 | 2019 |
| Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod G Mallucci, A Zito, B Dal Fabbro, R Bergamaschi Multiple Sclerosis and Related Disorders 45, 2020 | 22 | 2020 |
| Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients G Mallucci, A Zito, F Baldanti, M Gastaldi, B Dal Fabbro, D Franciotta, ... Multiple Sclerosis and Related Disorders 49, 102754, 2021 | 20 | 2021 |
| Vessel wall magnetic resonance imaging in COVID‐19‐associated cryptogenic ischemic stroke F Mazzacane, A Zito, S Magno, A Persico, V Mazzoleni, C Asteggiano, ... European Journal of Neurology 29 (2), 615-619, 2022 | 12 | 2022 |
| Signs and symptoms of COVID‐19 in patients with multiple sclerosis I Schiavetti, L Carmisciano, M Ponzano, C Cordioli, E Cocco, GA Marfia, ... European journal of neurology 29 (12), 3728-3736, 2022 | 9 | 2022 |
| The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis R Bergamaschi, M Ponzano, I Schiavetti, L Carmisciano, C Cordioli, ... European journal of neurology 29 (2), 535-542, 2022 | 7 | 2022 |
| Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: an exploratory case-control study in Italy R Giossi, A Consonni, VT Clerici, A Zito, E Rigoni, C Antozzi, L Brambilla, ... Multiple Sclerosis and Related Disorders 58, 103415, 2022 | 5 | 2022 |
| The long-COVID-19 in older adults: facts and conjectures TE Poloni, V Medici, A Zito, AF Carlos Neural Regeneration Research 17 (12), 2679-2681, 2022 | 4 | 2022 |
| How to forget a “traumatic” experience: a case report of transient global amnesia after nasopharyngeal swab for Coronavirus disease 19 S Ravaglia, A Zito, L Ahmad, I Canavero BMC neurology 21, 1-3, 2021 | 4 | 2021 |
| Buprenorphine may be effective for treatment of paramyotonia congenita S Ravaglia, L Maggi, A Zito, S Arceri, P Gallotti, C Altamura, JF Desaphy, ... Muscle & Nerve 64 (1), 95-99, 2021 | 3 | 2021 |
| A rare syndrome causing neurogenic dysphagia A Zito, P Bini, M Todisco, G Cosentino, S Mauramati, M Paoletti, ... Dysphagia 36, 1110-1113, 2021 | 2 | 2021 |
| PIRA among MS Patients Treated with Ocrelizumab and Alemtuzumab; A Real World Study F Polidoro, A Zito, C Neo, E Rigoni, V Singh-Curry, A Nandoskar, O Malik, ... MULTIPLE SCLEROSIS JOURNAL 28 (1_ SUPPL), 174-175, 2022 | 1 | 2022 |
| A multiscale assessment of bowel impairment in an Italian multiple sclerosis cohort E Tavazzi, A Zito, C Montomoli, N Bergsland, E Colombo, A La Malfa, ... Scientific Reports 13 (1), 21960, 2023 | | 2023 |
| B cells subsets, among MS patients treated with Ocrelizumab; a real world study S Herler, F Polidoro, A Zito, V Singh-Curry, A Nandoskar, ... MULTIPLE SCLEROSIS JOURNAL 29, 999-999, 2023 | | 2023 |
